Edgepark recently announced the addition of the Beta Bionics iLet Bionic Pancreas to its range of diabetes management solutions. This innovative fully automated insulin delivery (AID) system, designed for individuals six years and older living with Type 1 diabetes, marks a significant advancement in diabetes care. The iLet distinguishes itself as the first system to operate without the need for carbohydrate counting and completely automates insulin doses.

According to Edgepark, it is vital for individuals managing Type 1 diabetes to have access to the latest technologies that simplify care. The iLet represents a groundbreaking device that utilizes automation to streamline diabetes management, eliminating the manual tasks typically associated with insulin pump use.

The iLet system automatically administers basal, correction, and meal doses based on the user's real-time health data, offering users more flexibility in their daily routines. Additionally, it learns the user's unique patterns to personalize insulin adjustments, including typical carbohydrate intake during meals and necessary corrections.

Edgepark emphasizes the importance of the initial months in adapting to a new device for long-term success and adherence to therapy. To support patients, Edgepark offers a straightforward ordering process and ongoing assistance. Patients can explore available diabetes management therapies and supplies on Edgepark.com, ensuring they find the most suitable options for their medical and lifestyle needs with clear understanding of insurance coverage.

Upon placing an order, Edgepark coordinates directly with healthcare providers and insurance plans to verify eligibility and ensure seamless delivery to the patient's doorstep. With partnerships with over 1,900 health plans nationwide, all orders are eligible for free shipping. Moreover, Edgepark's ContinuCare program offers reminders and simplifies the ongoing at-home maintenance of therapy through an easy reorder process, enhancing patient experience and adherence to treatment.

Source: prnewswire.com

 

 

Report Abuse